MARINEMAX INC (HZO) Stock Fundamental Analysis

NYSE:HZO • US5679081084

29.73 USD
-1.13 (-3.66%)
At close: Mar 3, 2026
29.73 USD
0 (0%)
After Hours: 3/3/2026, 4:15:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HZO. HZO was compared to 123 industry peers in the Specialty Retail industry. HZO has a bad profitability rating. Also its financial health evaluation is rather negative. HZO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • HZO had positive earnings in the past year.
  • In the past year HZO had a positive cash flow from operations.
  • HZO had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: HZO reported negative operating cash flow in multiple years.
HZO Yearly Net Income VS EBIT VS OCF VS FCFHZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • HZO has a Return On Assets of -2.37%. This is in the lower half of the industry: HZO underperforms 62.60% of its industry peers.
  • HZO's Return On Equity of -6.18% is in line compared to the rest of the industry. HZO outperforms 46.34% of its industry peers.
  • HZO has a Return On Invested Capital of 2.27%. This is comparable to the rest of the industry: HZO outperforms 47.15% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HZO is significantly below the industry average of 13.61%.
Industry RankSector Rank
ROA -2.37%
ROE -6.18%
ROIC 2.27%
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
HZO Yearly ROA, ROE, ROICHZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • The Operating Margin of HZO (2.94%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of HZO has declined.
  • HZO has a worse Gross Margin (31.59%) than 60.16% of its industry peers.
  • In the last couple of years the Gross Margin of HZO has grown nicely.
Industry RankSector Rank
OM 2.94%
PM (TTM) N/A
GM 31.59%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
HZO Yearly Profit, Operating, Gross MarginsHZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HZO is destroying value.
  • Compared to 1 year ago, HZO has less shares outstanding
  • The number of shares outstanding for HZO remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for HZO is higher compared to a year ago.
HZO Yearly Shares OutstandingHZO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
HZO Yearly Total Debt VS Total AssetsHZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • HZO has an Altman-Z score of 1.85. This is not the best score and indicates that HZO is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.85, HZO perfoms like the industry average, outperforming 44.72% of the companies in the same industry.
  • The Debt to FCF ratio of HZO is 5.88, which is a neutral value as it means it would take HZO, 5.88 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.88, HZO is in the better half of the industry, outperforming 60.16% of the companies in the same industry.
  • HZO has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
  • HZO has a Debt to Equity ratio (1.13) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 5.88
Altman-Z 1.85
ROIC/WACC0.25
WACC8.97%
HZO Yearly LT Debt VS Equity VS FCFHZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.19 indicates that HZO should not have too much problems paying its short term obligations.
  • HZO's Current ratio of 1.19 is on the low side compared to the rest of the industry. HZO is outperformed by 60.16% of its industry peers.
  • HZO has a Quick Ratio of 1.19. This is a bad value and indicates that HZO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HZO has a Quick ratio of 0.29. This is in the lower half of the industry: HZO underperforms 73.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.29
HZO Yearly Current Assets VS Current LiabilitesHZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • HZO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.62%.
  • The earnings per share for HZO have been decreasing by -24.26% on average. This is quite bad
  • HZO shows a decrease in Revenue. In the last year, the revenue decreased by -1.10%.
  • Measured over the past years, HZO shows a quite strong growth in Revenue. The Revenue has been growing by 8.87% on average per year.
EPS 1Y (TTM)-77.62%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-223.53%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%7.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 43.00% on average over the next years. This is a very strong growth
  • HZO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y12.44%
EPS Next 2Y35.78%
EPS Next 3Y43%
EPS Next 5YN/A
Revenue Next Year2.85%
Revenue Next 2Y3.44%
Revenue Next 3Y3.83%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HZO Yearly Revenue VS EstimatesHZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
HZO Yearly EPS VS EstimatesHZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 63.26 indicates a quite expensive valuation of HZO.
  • The rest of the industry has a similar Price/Earnings ratio as HZO.
  • HZO's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.13.
  • Based on the Price/Forward Earnings ratio of 18.97, the valuation of HZO can be described as rather expensive.
  • HZO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HZO is cheaper than 65.04% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. HZO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 63.26
Fwd PE 18.97
HZO Price Earnings VS Forward Price EarningsHZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • HZO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HZO is cheaper than 71.54% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HZO is valued cheaply inside the industry as 95.94% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.55
EV/EBITDA 7.53
HZO Per share dataHZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HZO does not grow enough to justify the current Price/Earnings ratio.
  • HZO's earnings are expected to grow with 43.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.09
PEG (5Y)N/A
EPS Next 2Y35.78%
EPS Next 3Y43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HZO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MARINEMAX INC

NYSE:HZO (3/3/2026, 4:15:00 PM)

After market: 29.73 0 (0%)

29.73

-1.13 (-3.66%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners97.97%
Inst Owner Change-1.3%
Ins Owners2.85%
Ins Owner Change14.83%
Market Cap654.95M
Revenue(TTM)2.35B
Net Income(TTM)-57.62M
Analysts81.54
Price Target33.22 (11.74%)
Short Float %18.19%
Short Ratio8.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-81.02%
Min EPS beat(2)-230.66%
Max EPS beat(2)68.62%
EPS beat(4)2
Avg EPS beat(4)-34.43%
Min EPS beat(4)-230.66%
Max EPS beat(4)83.44%
EPS beat(8)4
Avg EPS beat(8)-4.44%
EPS beat(12)5
Avg EPS beat(12)-10.44%
EPS beat(16)8
Avg EPS beat(16)-4.53%
Revenue beat(2)2
Avg Revenue beat(2)2.95%
Min Revenue beat(2)2.61%
Max Revenue beat(2)3.28%
Revenue beat(4)3
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)0.38%
PT rev (1m)5.56%
PT rev (3m)-0.87%
EPS NQ rev (1m)-47.86%
EPS NQ rev (3m)-69.86%
EPS NY rev (1m)6.17%
EPS NY rev (3m)-49.92%
Revenue NQ rev (1m)2.42%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.89%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 63.26
Fwd PE 18.97
P/S 0.28
P/FCF 3.55
P/OCF 2.78
P/B 0.7
P/tB 1.77
EV/EBITDA 7.53
EPS(TTM)0.47
EY1.58%
EPS(NY)1.57
Fwd EY5.27%
FCF(TTM)8.38
FCFY28.2%
OCF(TTM)10.7
OCFY36%
SpS106.49
BVpS42.34
TBVpS16.84
PEG (NY)5.09
PEG (5Y)N/A
Graham Number21.16
Profitability
Industry RankSector Rank
ROA -2.37%
ROE -6.18%
ROCE 4.7%
ROIC 2.27%
ROICexc 2.45%
ROICexgc 3.41%
OM 2.94%
PM (TTM) N/A
GM 31.59%
FCFM 7.87%
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
ROICexc(3y)5.21%
ROICexc(5y)12.96%
ROICexgc(3y)7.5%
ROICexgc(5y)19.19%
ROCE(3y)9.35%
ROCE(5y)16.79%
ROICexgc growth 3Y-45.93%
ROICexgc growth 5Y-23.4%
ROICexc growth 3Y-45.55%
ROICexc growth 5Y-25.45%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 5.88
Debt/EBITDA 8.8
Cap/Depr 101.56%
Cap/Sales 2.18%
Interest Coverage 0.92
Cash Conversion 197.58%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.29
Altman-Z 1.85
F-Score5
WACC8.97%
ROIC/WACC0.25
Cap/Depr(3y)139.54%
Cap/Depr(5y)177.5%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.62%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-223.53%
EPS Next Y12.44%
EPS Next 2Y35.78%
EPS Next 3Y43%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%7.84%
Revenue Next Year2.85%
Revenue Next 2Y3.44%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y-53.43%
EBIT growth 3Y-27.02%
EBIT growth 5Y-1%
EBIT Next Year20.18%
EBIT Next 3Y14.51%
EBIT Next 5YN/A
FCF growth 1Y182.68%
FCF growth 3Y-12.94%
FCF growth 5Y-47.23%
OCF growth 1Y252.08%
OCF growth 3Y-1.68%
OCF growth 5Y-24.9%

MARINEMAX INC / HZO FAQ

Can you provide the ChartMill fundamental rating for MARINEMAX INC?

ChartMill assigns a fundamental rating of 3 / 10 to HZO.


What is the valuation status of MARINEMAX INC (HZO) stock?

ChartMill assigns a valuation rating of 4 / 10 to MARINEMAX INC (HZO). This can be considered as Fairly Valued.


Can you provide the profitability details for MARINEMAX INC?

MARINEMAX INC (HZO) has a profitability rating of 3 / 10.


Can you provide the financial health for HZO stock?

The financial health rating of MARINEMAX INC (HZO) is 3 / 10.